| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MUS.880110203 |
| P8608 | Fatcat ID | release_wvqkfxcopbdr5i3w75mzwqabiy |
| P698 | PubMed publication ID | 3343985 |
| P2093 | author name string | Parry GJ | |
| Clarke S | |||
| P433 | issue | 2 | |
| P304 | page(s) | 103-107 | |
| P577 | publication date | 1988-02-01 | |
| P1433 | published in | Muscle and Nerve | Q15764281 |
| P1476 | title | Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease | |
| P478 | volume | 11 |
| Q73739726 | 79(th) ENMC International Workshop: multifocal motor neuropathy. 14-15 April 2000, Hilversum, The Netherlands |
| Q71817931 | A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy |
| Q35489932 | A practical definition of conduction block in IvIg responsive multifocal motor neuropathy |
| Q35471156 | A variant of multifocal motor neuropathy with acute, generalised presentation and persistent conduction blocks |
| Q71013846 | AAEM case report #30: multifocal motor neuropathy |
| Q36227125 | Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis |
| Q40670480 | Antiglycolipid antibodies and peripheral neuropathies: links to pathogenesis. |
| Q42714089 | Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? |
| Q36075065 | Assessment of disease progression in motor neuron disease |
| Q30321200 | Assessment of temporal dispersion in motor nerves with normal conduction velocity. |
| Q36004627 | Associated autoimmune diseases in patients with multifocal motor neuropathy and their family members |
| Q73445111 | Asymmetric Acquired Demyelinating Polyneuropathies: MMN and MADSAM |
| Q73702435 | Atypical varieties of chronic inflammatory demyelinating neuropathies |
| Q51451889 | Central motor conduction time in patients with multifocal motor conduction block. |
| Q54518120 | Central nervous system involvement in multifocal demyelinating neuropathy with persistent conduction block. |
| Q82029183 | Chapter 11 Monomelic amyotrophy of upper or lower limbs |
| Q82029191 | Chapter 12 Multifocal and other motor neuropathies |
| Q68258723 | Chronic acquired demyelinating motor neuropathy |
| Q40939580 | Chronic immune-related demyelinating neuropathies |
| Q58880724 | Chronic motor axonal neuropathy |
| Q73747354 | Chronic motor axonal neuropathy associated with antibodies monospecific for N-acetylgalactosaminyl GD1a |
| Q70136327 | Chronic multifocal demyelinating neuropathy simulating motor neuron disease |
| Q51913584 | Correlation between distal motor latency and compound muscle action potential in amyotrophic lateral sclerosis. |
| Q48342549 | Cortical excitability in amyotrophic lateral sclerosis: a clue to pathogenesis. |
| Q56772380 | Demyelinating polyneuropathy with preferentially-proximal involvement |
| Q84787000 | Demyelinating symmetric motor polyneuropathy with high titers of anti‐GM1 antibodies |
| Q38224784 | Diagnosis and treatment of chronic acquired demyelinating polyneuropathies |
| Q80852673 | Diagnosis and treatment of multifocal motor neuropathy |
| Q41012559 | Diagnosis in neuromuscular diseases |
| Q44591915 | Diagnosis of amyotrophic lateral sclerosis |
| Q34235867 | Diagnosis of motor neuropathy |
| Q84316472 | Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition? |
| Q34044159 | Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders |
| Q39207150 | Electrophysiological improvement after intravenous immunoglobulin in motor neuropathy with multifocal conduction block |
| Q33235588 | European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society |
| Q33252355 | European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy |
| Q33715854 | Evaluation and rehabilitation of patients with adult motor neuron disease |
| Q48672941 | Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block |
| Q37550515 | Evidence-based treatment of chronic immune-mediated neuropathies |
| Q40670458 | Gangliosides and peripheral neuropathies: an overview. |
| Q41663659 | Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy |
| Q48006982 | IVIg dose increase in multifocal motor neuropathy: a prospective six month follow-up |
| Q24187418 | Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy |
| Q24200228 | Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy |
| Q24241391 | Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy |
| Q24246618 | Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy |
| Q37836898 | Immunotherapy of multifocal motor neuropathy |
| Q37329516 | Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update |
| Q24247007 | Intravenous immunoglobulin for multifocal motor neuropathy |
| Q24247868 | Intravenous immunoglobulin for multifocal motor neuropathy |
| Q49125609 | Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study |
| Q41589701 | Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies |
| Q40866049 | Intravenous immunoglobulin treatment of neurological autoimmune diseases |
| Q41012552 | Laboratory testing in peripheral nerve disease. |
| Q36317538 | Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy |
| Q33735714 | Long term follow up of multifocal motor neuropathy with conduction block under treatment |
| Q33729418 | MMN: from immunological cross-talk to conduction block |
| Q34510425 | Medical technology assessment. Electrodiagnosis in motor neuron diseases and amyotrophic lateral sclerosis. |
| Q44873193 | Motor neuron disease: a disease of old age. |
| Q68013954 | Multifocal motor neuropathy |
| Q71121001 | Multifocal motor neuropathy |
| Q81679400 | Multifocal motor neuropathy |
| Q73195249 | Multifocal motor neuropathy and Lewis Sumner syndrome: two distinct entities |
| Q91794528 | Multifocal motor neuropathy in Austria: a nationwide survey of clinical features and response to treatment |
| Q59270630 | Multifocal motor neuropathy mimicking motor neuron disease: nine cases |
| Q73259844 | Multifocal motor neuropathy presenting with respiratory failure |
| Q33734400 | Multifocal motor neuropathy with conduction block: a study of 24 patients |
| Q53047719 | Multifocal motor neuropathy with high titers of anti-MAG antibodies. |
| Q41702502 | Multifocal motor neuropathy without overt conduction block |
| Q28390264 | Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants |
| Q34204618 | Multifocal motor neuropathy. |
| Q37696931 | Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment |
| Q35467947 | Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block. |
| Q38091664 | Multifocal motor neuropathy: current therapies and novel strategies. |
| Q37959252 | Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies |
| Q48148537 | Multiple sclerosis presenting as lower motor neuron wasting and weakness of the distal upper extremity |
| Q38102612 | Natura non facit saltus in anti-ganglioside antibody-mediated neuropathies. |
| Q80247543 | Peripheral neuropathy |
| Q37910953 | Pharmacologic concerns of corticosteroids in the treatment of patients with immune-related neuromuscular diseases. |
| Q71535896 | Pitcher's arm: an electrodiagnostic enigma |
| Q24187755 | Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q24200900 | Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q24246631 | Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q46953615 | Prediction of response to IVIg treatment in patients with lower motor neurone disorders |
| Q50533932 | Proximal and proximo-distal bimelic amyotrophy: Evidence of cervical flexion induced myelopathy. |
| Q44538560 | Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier |
| Q37626132 | Subcutaneous immunoglobulin: opportunities and outlook |
| Q33996087 | Treatment of chronic inflammatory demyelinating polyneuropathy |
| Q79783574 | [Long-term follow-up of multifocal motor neuropathy with conduction block under intravenous immunoglobulin] |
| Q80880304 | [Multifocal motor neuropathy with persistent conduction blocks: 18 years on] |
| Q73869811 | [Multifocal motor neuropathy: an individualized disease of the peripheral nervous system] |
Search more.